Safety Study of BMS-770767 in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if BMS-770767 is safe, well tolerated, measure its
levels in the blood (pharmacokinetics), and measure the levels of chemicals (biomarkers) that
may be affected by this drug (pharmacodynamics) in a type 2 diabetes patient population